Objective:
To review approaches to expanding pediatric influenza vaccination and evidence on how vaccination timing during pregnancy may affect infant protection.
Approach:
- : Suchitra Rao, MD, discussed vaccine communication, missed opportunities and programs extending vaccination into inpatient, emergency and perioperative care.
- : Samantha M. Olson, MPH, presented a test-negative study of infants younger than six months with acute respiratory illness at seven U.S. pediatric medical centers across eight influenza seasons. Analyses compared maternal vaccination status and adjusted for infant age, site and calendar time.
- : Olson also reviewed modeling of earlier seasonal vaccine availability.
Key Findings:
- Pediatric influenza vaccination coverage declined from 63.7% in 2019–2020 to 49.4% in 2025–2026, according to CDC data presented by Rao.
- Among undervaccinated children hospitalized with influenza, 42% had an earlier missed vaccination opportunity at the institution that season. Subspecialty clinics were the most common setting.
- Children’s Hospital Colorado’s standardized emergency department and perioperative programs each resulted in 15 times the odds of vaccination. The emergency department program administered more than 1,000 vaccines in most seasons.
- Estimated effectiveness against infant influenza illness was 41% after maternal vaccination at or after 20 weeks’ gestation and 25% after earlier vaccination. Only the former estimate was statistically significant.
- Effectiveness was 44% among infants aged zero to two months and 25% among those aged three to five months; only the younger group’s estimate was statistically significant.
- Effectiveness was 66% when less than four months elapsed between maternal vaccination and infant illness, versus 25% at four to five months and 18% at six months or longer. Only the shortest-interval estimate was statistically significant.
- An updated analysis estimated 42% effectiveness following current-season-only maternal vaccination during pregnancy. Prior-season-only vaccination had an estimate of −1%, which was not statistically significant.
- Modeling suggested that starting vaccination eight weeks earlier could expand infant protection opportunities while maternal vaccination opportunities remained approximately unchanged.
Interpretation:
Additional health care encounters offer opportunities to vaccinate children. Maternal vaccination can provide antibodies that cross the placenta and protect infants, but Olson emphasized that pregnant people should not delay vaccination to optimize infant timing.
Limitations:
- The article does not provide the infant study’s sample size or confidence intervals.
- Several effectiveness estimates were not statistically significant.
- Earlier seasonal availability was evaluated through modeling; further research is needed on protection throughout the season.
- Results from the 11-site inpatient vaccination trial were forthcoming.
Conclusion:
Speakers emphasized tailored vaccine conversations, broader pediatric vaccination access and maternal vaccination without unnecessary delay. Olson stated that influenza vaccination can occur in any trimester and that preserving maternal protection remains essential.
Sources:
Based on findings from:
Rethinking influenza vaccination opportunities
Matthew Solan. Idsa Reporter, 2026.
https://idsareporter.com/issues/2026/november-2026/rethinking-influenza-vaccination-opportunities/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.